PHOENIX

PHOENIX

Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products

PHOENIX aims to enable the seamless, timely and cost-friendly transfer of nano-pharmaceuticals from lab bench to clinical trials by providing necessary advanced, affordable and easily accessible services through the Phoenix-OITB (open-innovation test-bed), that will be established as a novel legal entity in 2022.
Phoenix-OITB will offer a Single Entry Point for a consolidated network of facilities, technologies, services and expertise for all the technology transfer aspects from characterization, testing, verification up to scale-up, GMP compliant manufacturing and regulatory guidance.
The developments will we achieved in concrete work on 5 demo-cases with industry and SMEs; two open calls will be issued in the second half of the project.
RECENDT will contribute to the PHOENIX-targets by the development and application of analytical methods in the field of IR- & Raman-spectroscopic technologies, which shall later also be offered in the Phoenix-OITB service portfolio. Further, RECENDT will support in communication, dissemination and reach-out to the existing network in Austria.

Facts and Figures

  • Duration: 4 Jahre (01.03.2021 - 28.02.2025)
  • Funding: EU (H2020)
  • Projectpartner: 6 Company Partners; 6 Scientific Partners
  • Projectwebsite: www.phoenix-oitb.eu

Projectpartners

Company Partners:

⇒ Cenya Imaging
⇒ MyBiotech GmbH
⇒ Topas Therapeuthics GmbH
⇒ NANOMOL Technologies
⇒ LeanBioPro Company
⇒ Grace Bio S.L.

Scientific Partners:

⇒ BioNanoNet Forschungsgesellschaft mbH
⇒ CSIC Instituto de Nanociencia y Materiales de Aragon
⇒ Institute for Medical Research and Occupational Health
⇒ Luxembourg Institute of Science and Technology
⇒ RECENDT - Research Center for Non-Destructive Testing GmbH
⇒ Research Center for Pharmaceutical Engineering (RCPE)
Holzer Robert, Dipl.-Ing. -

Holzer Robert, Dipl.-Ing.
Contact Point, RECENDT GmbH

Downloads

Success Stories

Details about the successes of
the PAC-network you can find
in our Success Stories.

Publications

Journals
Conferences

 

The K-Projects PSSP, PAC and imPACts are set within FFG's COMET - funding-progam.

The strategic objectives of COMET are: developing new expertise by initiating and supporting long-term research co-operations between science and industry in toplevel research, and establishing and securing the technological leadership of companies. By advancing and bundling existing strengths and by integrating international research expertise Austria is to be strengthened as a research location for the long term.